Exogenous EGF and insulin in TCM media could reduce the sensitivity of the EGFR mutant and ALK-translocated NSCLC cells to EGFR or ALK inhibitors, respectively (10). The gene discussed is ALK; the disease is non-small cell lung carcinoma.